ERK-dependent downregulation of the atypical chemokine receptor D6 drives tumor aggressiveness in Kaposi sarcoma.
Savino B, Caronni N, Anselmo A, Pasqualini F, Borroni EM, Basso G, Celesti G, Laghi L, Tourlaki A, Boneschi V, Brambilla L, Nebuloni M, Vago G, Mantovani A, Locati M, Bonecchi R.
Savino B, et al. Among authors: vago g.
Cancer Immunol Res. 2014 Jul;2(7):679-89. doi: 10.1158/2326-6066.CIR-13-0202. Epub 2014 Apr 2.
Cancer Immunol Res. 2014.
PMID: 24844911